1 – 10 of 44
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Dynamic assessment of proliferation to guide response-adapted therapy in the setting of neoadjuvant chemotherapy in ER+/HER2- breast cancer
Saghir, Hani LU ; Veerla, Srinivas LU
; Loman, Niklas
LU
and Kimbung, Siker
LU
(2026)
In Translational Oncology
63.
- Contribution to journal › Article
-
Mark
Homologous recombination deficiency in primary ER-positive and HER2-negative breast cancer
Davies, Helen R ; Black, Daniella ; Kvist, Anders LU
; Sigurjónsdóttir, Kristín
LU
; Bosch, Ana
LU
; Bowden, Ramsay
; Memari, Yasin
; Chen, Ziqian
; Rinaldi, Giuseppe
and Rosengren, Frida
LU
, et al.
(2026)
In Communications medicine
6(1).
- Contribution to journal › Article
-
Mark
Multiomics assessment of lung adenocarcinoma subtypes defined through tumor purity-adjusted DNA methylation
Nacer, Deborah F LU
; Arbajian, Elsa
LU
; Veerla, Srinivas
LU
; Aine, Mattias
LU
; Jönsson, Mats
LU
; Rosengren, Frida
LU
; Karlsson, Anna
LU
; Salomonsson, Annette
LU
; Isaksson, Sofi
LU
and Planck, Maria
LU
, et al.
(2026)
In Genome Medicine
18.
p.1-21
- Contribution to journal › Article
-
Mark
Tumor microenvironment transcriptional activity enables robust stratification of chemotherapy response in triple-negative breast cancer
- Contribution to journal › Article
- 2025
-
Mark
Copy number signatures in cervical samples enable early detection of high-grade serous ovarian carcinoma
Veerla, Srinivas LU
; Martin de la Fuente, Laura
LU
; Li, Minerva
LU
; Tang, Guyuan
; Ebbesson, Anna
LU
; D'Incalci, Maurizio
; Marchini, Sergio
; Mannarino, Laura
; Måsbäck, Anna
LU
and Malander, Susanne
LU
, et al.
(2025)
SCRM 2025 - the 7th Swedish Cancer Research Meeting
- Contribution to conference › Poster
-
Mark
Intrathecal pemetrexed for leptomeningeal metastases in a patient with ALK-rearranged lung adenocarcinoma : a case report
- Contribution to journal › Article
-
Mark
Global Transcriptional Complexity of Estrogen Receptor Low Positive Breast Cancers in a Prospective Swedish Population-based SCAN-B Cohort
Kimbung, Siker LU ; Veerla, Srinivas LU
; Muhammad, Kadum
; Ehinger, Anna
LU
; Vallon-Christersson, Johan
LU
; Malmberg, Martin
LU
and Loman, Niklas
LU
(2025)
In Clinical cancer research : an official journal of the American Association for Cancer Research
31(13).
p.2695-2709
- Contribution to journal › Article
-
Mark
Genomic characterization of the HER2-enriched intrinsic molecular subtype in primary ER-positive HER2-negative breast cancer
Hohmann, Lennart LU
; Sigurjonsdottir, Kristin
LU
; Campos, Ana Bosch
LU
; Nacer, Deborah F.
LU
; Veerla, Srinivas
LU
; Rosengren, Frida
LU
; Reddy, Poojaswini Thimmaraya
LU
; Häkkinen, Jari
LU
; Nordborg, Nicklas
LU
and Vallon-Christersson, Johan
LU
, et al.
(2025)
In Nature Communications
16.
p.1-17
- Contribution to journal › Article
-
Mark
The DNA methylation landscape of primary triple-negative breast cancer
Aine, Mattias LU ; Nacer, Deborah F LU
; Arbajian, Elsa
LU
; Veerla, Srinivas
LU
; Karlsson, Anna
LU
; Häkkinen, Jari
LU
; Johansson, Henrik J
; Rosengren, Frida
LU
; Vallon-Christersson, Johan
LU
and Borg, Åke
LU
, et al.
(2025)
In Nature Communications
16.
p.1-23
- Contribution to journal › Article
-
Mark
Evaluation of alternative prognostic thresholds for SP142 and 22C3 immunohistochemical PD-L1 expression in triple-negative breast cancer : results from a population-based cohort
Sigurjonsdottir, Gudbjörg LU ; De Marchi, Tommaso LU ; Ehinger, Anna LU
; Hartman, Johan
; Ullén, Susann
LU
; Leandersson, Karin
LU
; Bosch, Ana
LU
; Staaf, Johan
LU
; Killander, Fredrika
LU
and Niméus, Emma
LU
(2025)
In Breast Cancer Research and Treatment
210(2).
p.271-284
- Contribution to journal › Article